Furthermore, we observed that a monoclonal anti-JAM-C antibody decreased the severity of mouse antigen-induced arthritis (AIA) and delayed the onset of K/BxN serum transfer-induced arthritis. This evidence concerns the gene JAM3 and Arthritis.